• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞芬太尼与心脏麻醉期间及术后的肺摄取

Remifentanil and pulmonary extraction during and after cardiac anesthesia.

作者信息

Duthie D J, Stevens J J, Doyle A R, Baddoo H H, Gupta S K, Muir K T, Kirkham A J

机构信息

Department of Anaesthesia, Papworth Hospital, Cambridge, United Kingdom.

出版信息

Anesth Analg. 1997 Apr;84(4):740-4. doi: 10.1097/00000539-199704000-00007.

DOI:10.1097/00000539-199704000-00007
PMID:9085949
Abstract

We measured the apparent blood clearance and pulmonary extraction ratio of remifentanil in 10 adult patients undergoing elective myocardial revascularization for the first time with hypothermic cardiopulmonary bypass (CPB). Patients received continuous infusions of remifentanil 1.0, 1.5 or 2.0 microg x kg(-1) x min(-1). After surgery, remifentanil was infused at 1.0 microg x kg(-1) x min(-1) in all patients. Remifentanil concentrations were measured in pulmonary and radial artery blood by gas chromatography with high resolution mass spectrometry before and after CPB and 165 min (60 SD) after surgery. Cardiac output was measured by thermodilution at the time of blood sampling. The mean pulmonary extraction ratio of remifentanil was 5.7% (13.1% SD), which was not significantly different from zero. However, pulmonary extraction ratio was related inversely to the pulmonary artery hydrogen ion concentration and directly to the percent of nonionized form of the base in the pulmonary artery. Remifentanil concentrations in pulmonary and radial artery blood were related directly to infusion rate, but not to duration of infusion. There was no evidence of accumulation or sequestration. Mean apparent blood remifentanil clearance was 2.03 L/min (0.35 SD) and, in contrast to remifentanil pulmonary extraction ratio, was related directly to cardiac index and oxygen delivery. Increased tissue perfusion increased blood remifentanil clearance. We found predictable blood remifentanil levels with no evidence of accumulation or pulmonary extraction.

摘要

我们测量了10例首次接受择期心肌血运重建术并采用低温体外循环(CPB)的成年患者中瑞芬太尼的表观血清除率和肺摄取率。患者接受1.0、1.5或2.0微克·千克⁻¹·分钟⁻¹的瑞芬太尼持续输注。术后,所有患者均以1.0微克·千克⁻¹·分钟⁻¹的速度输注瑞芬太尼。在CPB前后以及术后165分钟(标准差60分钟),通过气相色谱-高分辨率质谱法测量肺和桡动脉血中的瑞芬太尼浓度。在采血时通过热稀释法测量心输出量。瑞芬太尼的平均肺摄取率为5.7%(标准差13.1%),与零无显著差异。然而,肺摄取率与肺动脉氢离子浓度呈负相关,与肺动脉中碱基非离子化形式的百分比呈正相关。肺和桡动脉血中的瑞芬太尼浓度与输注速率直接相关,但与输注持续时间无关。没有蓄积或潴留的证据。瑞芬太尼的平均表观血清除率为2. 03升/分钟(标准差0. 35),与瑞芬太尼肺摄取率不同,它与心脏指数和氧输送直接相关。组织灌注增加会提高血中瑞芬太尼清除率。我们发现瑞芬太尼血药浓度可预测,且没有蓄积或肺摄取的证据。

相似文献

1
Remifentanil and pulmonary extraction during and after cardiac anesthesia.瑞芬太尼与心脏麻醉期间及术后的肺摄取
Anesth Analg. 1997 Apr;84(4):740-4. doi: 10.1097/00000539-199704000-00007.
2
The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.瑞芬太尼在接受体外循环冠状动脉搭桥术患者中的药代动力学。
Anesth Analg. 2001 Nov;93(5):1100-5. doi: 10.1097/00000539-200111000-00006.
3
Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil.温度和体外循环对瑞芬太尼药代动力学的影响。
Br J Anaesth. 1997 Oct;79(4):456-9. doi: 10.1093/bja/79.4.456.
4
The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair.体外循环对房间隔缺损修补术患儿瑞芬太尼药代动力学的影响。
Anesth Analg. 1999 Oct;89(4):904-8. doi: 10.1097/00000539-199910000-00016.
5
Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.瑞芬太尼在接受择期手术或诊断性操作的麻醉小儿患者中的药代动力学。
Anesth Analg. 2001 Dec;93(6):1393-401, table of contents. doi: 10.1097/00000539-200112000-00008.
6
The use of a remifentanil infusion for hemodynamic control during intracranial surgery.瑞芬太尼输注用于颅内手术期间的血流动力学控制。
Anesth Analg. 1999 Nov;89(5):1282-7.
7
Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery.瑞芬太尼(GI87084B)及其主要代谢产物(GI90291)在择期住院手术患者中的药代动力学。
Anesthesiology. 1993 Nov;79(5):893-903. doi: 10.1097/00000542-199311000-00005.
8
Efficacy and safety of remifentanil in coronary artery bypass graft surgery: a randomized, double-blind dose comparison study.瑞芬太尼在冠状动脉旁路移植手术中的疗效和安全性:一项随机、双盲剂量比较研究。
J Cardiothorac Vasc Anesth. 2003 Feb;17(1):60-8. doi: 10.1053/jcan.2003.11.
9
The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.短效阿片类激动剂瑞芬太尼在雄性比格犬恒速输注期间的药代动力学和肝外清除率。
Drug Metab Dispos. 1996 Jan;24(1):34-40.
10
Assessment of depth of anesthesia and postoperative respiratory recovery after remifentanil- versus alfentanil-based total intravenous anesthesia in patients undergoing ear-nose-throat surgery.在接受耳鼻喉手术的患者中,比较瑞芬太尼与阿芬太尼全凭静脉麻醉下的麻醉深度及术后呼吸恢复情况。
Anesthesiology. 2001 Feb;94(2):211-7. doi: 10.1097/00000542-200102000-00008.

引用本文的文献

1
A dose-ranging study of the physiological and self-reported effects of repeated, rapid infusion of remifentanil in people with opioid use disorder and physical dependence on fentanyl.一项重复、快速输注瑞芬太尼对阿片类药物使用障碍和身体依赖芬太尼者生理和自我报告影响的剂量范围研究。
Psychopharmacology (Berl). 2024 Jun;241(6):1227-1236. doi: 10.1007/s00213-024-06557-1. Epub 2024 Feb 22.
2
The clinical pharmacology of remifentanil: a brief review.瑞芬太尼的临床药理学:简要综述。
J Anesth. 1998 Dec;12(4):195-204. doi: 10.1007/BF02481730.
3
Population pharmacokinetics of remifentanil in infants and children undergoing cardiac surgery.
婴幼儿心脏手术患者瑞芬太尼的群体药代动力学。
BMC Anesthesiol. 2009 Jul 27;9:5. doi: 10.1186/1471-2253-9-5.